Completion of Tender Offer

Summary by AI ^BETAClose X

Bellevue Healthcare Trust plc has completed its tender offer, acquiring 29,922,562 ordinary redeemable shares, which will be held in treasury. Payment for these shares is expected by March 20, 2026. Following this transaction, the company now holds 271,875,637 shares in treasury, with 43,276,672 shares remaining in issue. The company is also set to be renamed CT Healthcare Trust plc.

Disclaimer*

Bellevue Healthcare Trust PLC

06 March 2026

6 March 2026

THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH ITS DISTRIBUTION MAY BE UNLAWFUL

Bellevue Healthcare Trust plc (the "Company")

{to be renamed CT Healthcare Trust plc}

Completion of Tender Offer

Further to the announcement made by the Company on 4 March 2026, the Company announces that it has acquired 29,922,562 ordinary redeemable shares of £0.01 each in the capital of the Company (the "Shares") pursuant to the tender offer launched by the Company on 12 February 2026 (the "Tender Offer"). All Shares repurchased by the Company will be held in treasury.

Payment to shareholders of the Tender Offer consideration is expected to be made by 20 March 2026.

Following the above transaction, the Company holds 271,875,637 of its Shares in treasury and has 43,276,672 Shares in issue (excluding treasury shares).

For further information, please contact:

Bellevue Healthcare Trust plc
Kate Bolsover, Chairman	c/o Burson Buchanan

Columbia Threadneedle Investments	+44 (0) 207 464 5000
Marrack Tonkin
Burson Buchanan	+44 (0) 7788 528143
Henry Wilson / Helen Tarbet / Jesse McNab	BBH@buchanan.uk.com

JP Morgan Cazenove	+44 (0) 20 3493 8000
William Simmonds / Rupert Budge	BBH_JPMC@jpmorgan.com

NSM Funds (UK) Ltd	+44 (0) 20 3697 5770
Brian Smith / Ciara McKillop	bellevue@nsm.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END